Piriev N I, Shih J M, Farber D B
Jules Stein Eye Institute, University of California, Los Angeles School of Medicine 90095, USA.
Invest Ophthalmol Vis Sci. 1998 Mar;39(3):463-70.
The authors have previously reported a 3' splice site mutation in intron 2 of the rod cyclic guanosine monophosphate-phosphodiesterase (cGMP) beta-subunit (beta-PDE) gene in a patient with compound heterozygous autosomal recessive retinitis pigmentosa. The purpose of this study is to determine whether this mutation interferes with RNA splicing, what products it generates, and whether the resultant mRNA is able to support the synthesis of the native protein.
Two expression constructs were prepared by subcloning genomic DNA fragments (one from the control subject DNA and the other from the patient's DNA) to the pCIS2 expression vector. Recombinant plasmid DNA was introduced into 293 human embryonic kidney cells using the calcium phosphate-mediated transfection procedure. Northern blot hybridization, reverse transcription-polymerase chain reaction, and sequencing were used for RNA analysis.
Four major products were present in the RNA pool isolated from cells transfected with the expression construct containing the splice site mutation. One of the transcripts resulted from the activation of a cryptic 3' splice site located in exon 3, 12 nucleotides downstream of the mutated site. The second fragment was longer than the correctly spliced mRNA by approximately 1 kb and contained unspliced intron 2. Two other high molecular weight products corresponded to intermediate lariats.
An acceptor splice site mutation in intron 2 of the beta-PDE gene leads to the accumulation of pre-mRNA and intermediate lariats and a 12-nucleotide shorter beta-PDE transcript produced by the use of a cryptic splice site located in exon 3. In the normal beta-PDE mRNA, these 12 nucleotides code for ValPheLeuLys. These amino acids are highly conserved in the putative noncatalytic cGMP-binding domain I of beta-PDE from several species and, probably, are important for the correct folding and function of the protein.
作者先前报道了一名患有复合杂合性常染色体隐性视网膜色素变性患者的视杆细胞环磷酸鸟苷磷酸二酯酶(cGMP)β亚基(β - PDE)基因内含子2中的一个3'剪接位点突变。本研究的目的是确定该突变是否干扰RNA剪接,产生何种产物,以及所得的mRNA是否能够支持天然蛋白质的合成。
通过将基因组DNA片段(一个来自对照受试者DNA,另一个来自患者DNA)亚克隆到pCIS2表达载体中,制备了两种表达构建体。使用磷酸钙介导的转染程序将重组质粒DNA导入293人胚肾细胞。Northern印迹杂交、逆转录 - 聚合酶链反应和测序用于RNA分析。
从转染了含有剪接位点突变表达构建体的细胞中分离的RNA池中存在四种主要产物。其中一种转录本是由位于突变位点下游12个核苷酸的外显子3中一个隐蔽的3'剪接位点的激活产生的。第二个片段比正确剪接的mRNA长约1 kb,并包含未剪接的内含子2。另外两种高分子量产物对应于中间套索状结构。
β - PDE基因内含子2中的一个受体剪接位点突变导致前体mRNA和中间套索状结构的积累,以及通过使用位于外显子3中的一个隐蔽剪接位点产生的一个短12个核苷酸的β - PDE转录本。在正常β - PDE mRNA中,这12个核苷酸编码ValPheLeuLys。这些氨基酸在几种物种的β - PDE假定的非催化cGMP结合结构域I中高度保守,并且可能对蛋白质的正确折叠和功能很重要。